These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30338233)

  • 1. Differential effect of metformin and/or glyburide on apelin serum levels in patients with type 2 diabetes mellitus: Concepts and clinical practice.
    Al-Kuraishy HM; Al-Gareeb AI; Waheed HJ; Al-Maiahy TJ
    J Adv Pharm Technol Res; 2018; 9(3):80-86. PubMed ID: 30338233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic profile and prolactin serum levels in men with type 2 diabetes mellitus: Old-new rubric.
    Al-Nami MS; Al-Kuraishy HM; Al-Gareeb AI; Al-Mamoori F
    Int J Crit Illn Inj Sci; 2019; 9(3):120-126. PubMed ID: 31620350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of diabetic pharmacotherapy on prolactin hormone in patients with type 2 diabetes mellitus: Bane or Boon.
    Rasheed HA; Al-Kuraishy HM; Al-Gareeb AI; Hussien NR; Al-Nami MS
    J Adv Pharm Technol Res; 2019; 10(4):163-168. PubMed ID: 31742116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
    Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N
    Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
    Cunha MR; Silva ME; Machado HA; Fukui RT; Correia MR; Santos RF; Wajchenberg BL; Rocha DM; Rondon MU; Negrão CE; Ursich MJ
    Diabetes Obes Metab; 2008 Mar; 10(3):238-45. PubMed ID: 18269639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of Serum Apelin and Insulin Resistance in Type 2 Diabetes Mellitus Patients With or Without Obesity.
    Mund C; Kellellu CK; Rattan R; Mahapatra S; Lamare AA; Jena S
    Cureus; 2023 Aug; 15(8):e43401. PubMed ID: 37706122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the relationship between serum apelin levels and vitamin D and mean platelet volume in diabetic patients.
    Kiskac M; Zorlu M; Cakirca M; Karatoprak C; Kesgin S; Büyükaydın B; Yavuz E; Ardic C; Camli AA; Cikrikcioglu MA
    Ann Endocrinol (Paris); 2014 Sep; 75(4):200-5. PubMed ID: 25156130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
    Erdem G; Dogru T; Tasci I; Sonmez A; Tapan S
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):289-92. PubMed ID: 18484561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of thioctic acid on glycemic indices and associated inflammatory-induced endothelial dysfunction in patients with type 2 diabetes mellitus: A case control study.
    Al-Nami MS; Al-Kuraishy HM; Al-Gareeb AI
    Int J Crit Illn Inj Sci; 2020 Sep; 10(Suppl 1):21-27. PubMed ID: 33376686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between FTO gene polymorphisms and type 2 diabetes mellitus, serum levels of apelin and androgen hormones among Iranian obese women.
    Ghafarian-Alipour F; Ziaee S; Ashoori MR; Zakeri MS; Boroumand MA; Aghamohammadzadeh N; Abbasi-Majdi M; Shool F; Asbaghi NS; Mohammadi A; Zarghami N
    Gene; 2018 Jan; 641():361-366. PubMed ID: 29101069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum apelin and ADMA levels in type 2 diabetics with and without vascular complications.
    Karakoç A; Sahin A; Polat ES; Aliyev E; Yildirim A; Bakan N; Dokumacioglu E
    Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S106-9. PubMed ID: 27083312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of serum apelin-13 associated with proliferative diabetic retinopathy in type 2 diabetic patients.
    Du JH; Li X; Li R; Xu L; Ma RR; Liu SF; Zhang Z; Sun HZ
    Int J Ophthalmol; 2014; 7(6):968-73. PubMed ID: 25540748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: a single-center, multiple-dose, open-label study.
    Rao N; Chou T; Ventura D; Abramowitz W
    Clin Ther; 2005 Oct; 27(10):1596-606. PubMed ID: 16330295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin and/or vildagliptin mitigate type II diabetes mellitus induced-oxidative stress: The intriguing effect.
    Al-Kuraishy HM; Sami OM; Hussain NR; Al-Gareeb AI
    J Adv Pharm Technol Res; 2020; 11(3):142-147. PubMed ID: 33102198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes and metabolic syndrome - adipokine levels and effect of drugs.
    Farooq R; Amin S; Hayat Bhat M; Malik R; Wani HA; Majid S
    Gynecol Endocrinol; 2017 Jan; 33(1):75-78. PubMed ID: 27705028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-Cause and Cardiovascular Mortality following Treatment with Metformin or Glyburide in Patients with Type 2 Diabetes Mellitus.
    Raee MR; Nargesi AA; Heidari B; Mansournia MA; Larry M; Rabizadeh S; Zarifkar M; Esteghamati A; Nakhjavani M
    Arch Iran Med; 2017 Mar; 20(3):141-146. PubMed ID: 28287807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction and inflammatory biomarkers as a response factor of concurrent coenzyme Q10 add-on metformin in patients with type 2 diabetes mellitus.
    Al-Kuraishy HM; Al-Gareeb AI; Shams HA; Al-Mamorri F
    J Lab Physicians; 2019; 11(4):317-322. PubMed ID: 31929697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Apelin and Insulin Resistance in Patients with PCOS and Therapeutic Effect of Drospirenone-Ethinylestradiol Plus Metformin.
    Sun X; Wu X; Zhou Y; Yu X; Zhang W
    Med Sci Monit; 2015 Aug; 21():2547-52. PubMed ID: 26314870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus.
    Hung YC; Lin CC; Wang TY; Chang MP; Sung FC; Chen CC
    Diabetes Metab Res Rev; 2013 Nov; 29(8):673-9. PubMed ID: 23956007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.